Evidence map›Paper›PMID 38488950›Full record

ArticleAntonie van Leeuwenhoek2024

Antimicrobial peptides designed by computational analysis of proteomes.

Dahiana Monsalve, Andrea Mesa, Laura M Mira, Carlos Mera, Sergio Orduz, John W Branch-Bedoya

Abstract read
PubMed Publisher
In one paragraph

Article in Antonie van Leeuwenhoek, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dahiana MonsalveEscuela de Biociencias, Departamento de Ciencias, Universidad Nacional de Colombia, sede Medellín, Carrera 65 # 59A-110, 050034, Medellín, Antioquia, Colombia.ORCID https://orcid.org/0009-0006-2511-222X
Andrea MesaEscuela de Biociencias, Departamento de Ciencias, Universidad Nacional de Colombia, sede Medellín, Carrera 65 # 59A-110, 050034, Medellín, Antioquia, Colombia.ORCID https://orcid.org/0000-0002-5387-3732
Laura M MiraEscuela de Biociencias, Departamento de Ciencias, Universidad Nacional de Colombia, sede Medellín, Carrera 65 # 59A-110, 050034, Medellín, Antioquia, Colombia.ORCID https://orcid.org/0000-0002-7169-6290
Carlos MeraDepartamento de Sistemas de Información, Instituto Tecnológico Metropolitano, Calle 54A # 30-01, 050013, Medellín, Antioquia, Colombia. carlosmera@itm.edu.co.ORCID https://orcid.org/0000-0002-6513-3053
Sergio OrduzEscuela de Biociencias, Departamento de Ciencias, Universidad Nacional de Colombia, sede Medellín, Carrera 65 # 59A-110, 050034, Medellín, Antioquia, Colombia.ORCID https://orcid.org/0000-0001-7587-3816
John W Branch-BedoyaDepartamento de Ciencias de la Computación y de la Decisión, Facultad de Minas, Universidad Nacional de Colombia, sede Medellín, Av. 80 # 65-223, 050041, Medellín, Antioquia, Colombia.ORCID https://orcid.org/0000-0002-0378-028X
Universidad de Antioquia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are promising cationic and amphipathic molecules to fight antibiotic resistance. To search for novel AMPs, we applied a computational strategy to identify peptide sequences within the organisms' proteome, including in-house developed software and artificial intelligence tools. After analyzing 150.450 proteins from eight proteomes of bacteria, plants, a protist, and a nematode, nine peptides were selected and modified to increase their antimicrobial potential. The 18 resulting peptides were validated by bioassays with four pathogenic bacterial species, one yeast species, and two cancer cell-lines. Fourteen of the 18 tested peptides were antimicrobial, with minimum inhibitory concentrations (MICs) values under 10 µM against at least three bacterial species; seven were active against Candida albicans with MICs values under 10 µM; six had a therapeutic index above 20; two peptides were active against A549 cells, and eight were active against MCF-7 cells under 30 µM. This study's most active antimicrobial peptides damage the bacterial cell membrane, including grooves, dents, membrane wrinkling, cell destruction, and leakage of cytoplasmic material. The results confirm that the proposed approach, which uses bioinformatic tools and rational modifications, is highly efficient and allows the discovery, with high accuracy, of potent AMPs encrypted in proteins.

Indexed as

Anti-Infective AgentsProteomeAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesArtificial IntelligenceBacteriaMicrobial Sensitivity TestsAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesProteomeAntimicrobial peptidesCheminformaticsComputational biologyMachine learning

Identifiers

PMID38488950
OpenAlexW4392871352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.